We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.82%
2 Technology 2.79%
3 Financials 2.26%
4 Consumer Discretionary 1.92%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWAV
14326
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
-48,505
Closed -$8.56M
BREZR
14327
DELISTED
Breeze Holdings Acquisition Corp. Right
BREZR
-12,600
Closed -$2K
AMJ
14328
PUT
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
-10,800
Closed -$226K
AIH
14329
DELISTED
Aesthetic Medical International Holdings
AIH
-10,100
Closed -$16K
CAMP
14330
DELISTED
CalAmp Corp.
CAMP
-599
Closed -$101K
ENG
14331
DELISTED
ENGlobal Corp
ENG
-4,028
Closed -$36.7K
GENE
14332
CALL
DELISTED
Genetic Technologies Ltd.
GENE
-5,720
Closed -$56K
GENE
14333
PUT
DELISTED
Genetic Technologies Ltd.
GENE
-6,120
Closed -$60K
ZFOXW
14334
DELISTED
ZeroFox Holdings, Inc. Warrants
ZFOXW
-433,468
Closed -$132K
NBSE
14335
CALL
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
-805
Closed -$30K
VAXX
14336
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
-10,766
Closed -$46K
AGTI
14337
DELISTED
Agiliti Inc
AGTI
-673,612
Closed -$14.2M
CONXW
14338
DELISTED
CONX Corp. Warrant
CONXW
-167,082
Closed -$70K
VINO
14339
PUT
DELISTED
Gaucho Group Holdings, Inc. Common Stock
VINO
-17
Closed -$53K
RMGCW
14340
DELISTED
RMG Acquisition Corp. III Warrant
RMGCW
-180,000
Closed -$79K
RMGCU
14341
DELISTED
RMG Acquisition Corp. III Unit
RMGCU
-11,671
Closed -$115K
DCFC
14342
DELISTED
Tritium DCFC Limited Ordinary Shares
DCFC
-381
Closed -$627K
DCFC
14343
PUT
DELISTED
Tritium DCFC Limited Ordinary Shares
DCFC
-89
Closed -$178K
GMDA
14344
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
-32,577
Closed -$82.8K
GMDA
14345
PUT
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
-46,200
Closed -$192K
VIEW
14346
PUT
DELISTED
View, Inc. Class A Common Stock
VIEW
-395
Closed -$44K
CCLP
14347
DELISTED
CSI Compressco LP
CCLP
-20,627
Closed -$29K
CSTR
14348
CALL
DELISTED
CapStar Financial Holdings, Inc
CSTR
-13,100
Closed -$276K
DSKE
14349
CALL
DELISTED
Daseke, Inc. Common Stock
DSKE
-21,100
Closed -$212K
PGTI
14350
PUT
DELISTED
PGT, Inc.
PGTI
-18,400
Closed -$331K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.